Related Experiment Video
Updated: Jul 16, 2025

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
Future Directions of Allergen Immunotherapy for Allergic Rhinitis: Experts' Perspective.
Oliver Pfaar1, Jay Portnoy2, Hendrik Nolte3
1Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
Allergen immunotherapy (AIT) is a key treatment for allergies. This expert review identifies 7 unmet needs and future directions for AIT, including new application routes and diagnostic tools.
Area of Science:
- Immunology
- Allergology
- Clinical Medicine
Background:
- Allergen immunotherapy (AIT) is the only disease-modifying treatment for allergies.
- Significant unmet needs exist in optimizing AIT efficacy and application.
Purpose of the Study:
- To address 7 critical unmet needs in Allergen Immunotherapy (AIT).
- To provide expert perspectives on the future direction and innovation in AIT.
Main Methods:
- An international expert group formulated 7 key aspects for AIT's future.
- A comprehensive literature review was conducted.
- A consented position on discussed topics was established.
Main Results:
- Identified 7 key areas for AIT advancement: alternative routes, recombinant vaccines, component-resolved diagnosis (CRD) for AIT composition, COVID-19 vaccination impact, combining biologics with AIT, innovations for high-risk populations, and regulatory considerations.
- Authors elaborated on their expert views and positions for each aspect.
Conclusions:
- Addressing these 7 unmet needs is crucial for advancing Allergen Immunotherapy.
- Future innovations in AIT require exploration of novel approaches, diagnostics, and regulatory frameworks.
Related Concept Videos
Allergic Reactions
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-I: Introduction

